TENI DM

Teneligliptin 20 mg + Metformin 500 mg Tablets

An oral anti-diabetic combination tablet containing Teneligliptin and Metformin, formulated to help improve blood sugar control in patients with type 2 diabetes mellitus. The dual mechanism helps regulate both fasting and post-meal glucose levels effectively.

Key Benefits

• Helps control blood sugar levels effectively
• Improves fasting and post-prandial glucose control
• Supports better insulin sensitivity
• Helps reduce glucose production in the liver
• Convenient combination therapy for diabetes management
• Supports long-term glycaemic control

Mechanism of Action

Teneligliptin is a DPP-4 inhibitor that works by increasing incretin levels, which enhance insulin release and reduce glucagon secretion in a glucose-dependent manner. This helps lower blood glucose levels.

Metformin is a biguanide that decreases hepatic glucose production, improves insulin sensitivity, and reduces intestinal glucose absorption.

Together, the combination provides complementary glucose-lowering effects for better glycaemic control.

Indications

• Type 2 diabetes mellitus
• Inadequate glycaemic control with single therapy
• Fasting and post-meal blood sugar management
• Insulin resistance management (as advised by physician)
• Adjunct to diet and exercise in diabetes control